News
- Author:
- Jim Kling
Publish date: June 20, 2022
“This study should make clinicians cognizant of the potential for biases in management of metastatic breast cancer in terms of socioeconomic status...
News
- Author:
- Jim Kling
Publish date: June 14, 2022
Retrospective data hint at antitumor activity, but other explanations are possible
News
- Author:
- Jim Kling
Publish date: June 14, 2022
Research model suggests a 58% overall mortality decline in 2019 from metastatic breast cancer.
News
- Author:
- Jim Kling
Publish date: June 7, 2022
A better understanding of this common comorbidity could lead to better management and treatment.
News
- Author:
- Jim Kling
Publish date: June 5, 2022
The results may cause clinicians to reconsider how they define HER2 expression in breast cancer.
News
- Author:
- Jim Kling
Publish date: June 5, 2022
Expert calls advance incremental, but clinically important for women with HR positive/HER2 negative breast cancer.
News
- Author:
- Jim Kling
Publish date: June 5, 2022
Personalized surveillance technique has the potential to augment adjuvant therapy and improve long-term outcomes.
News
- Author:
- Jim Kling
Publish date: June 3, 2022
The combination led to reduced progression with good tolerability in metastatic, hormone receptor–positive patients.
News
- Author:
- Jim Kling
Publish date: June 3, 2022
Three cycles of neoadjuvant nivolumab plus chemotherapy improved long-term clinical outcomes in resectable stage IB-IIIA NSCLC.
News
- Author:
- Jim Kling
Publish date: June 1, 2022
Trial returns a negative result for the RANKL inhibitor, but identifies favored schedule for nab-paclitaxel.
News
- Author:
- Jim Kling
Publish date: May 31, 2022
Trends of increased mortality in all women seem to be driven by non-endometrioid tumors.
News
- Author:
- Jim Kling
Publish date: May 27, 2022
“We just look at [our patients] and we say, ‘Their skin color looks black, and therefore we’re going to apply a different equation to them.’ ”
News
- Author:
- Jim Kling
Publish date: May 26, 2022
Overlap was less common in eosinophilic esophagitis, but more common in eosinophilic gastritis/eosinophilic gastroenteritis.
News
- Author:
- Jim Kling
Publish date: May 26, 2022
Bariatric surgery’s benefits have been well documented, but endoscopic sleeve gastroplasty is relatively new, so its outcomes haven’t been as well ...
News
- Author:
- Jim Kling
Publish date: May 24, 2022
Swallowed device may work by boosting natural colonic rhythms, whereas traditional treatments for constipation generally increase motility or secre...
